Prem S Shah is EVP and Group President of CVS HEALTH Corp. Currently has a direct ownership of 42,034 shares of CVS, which is worth approximately $1.86 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 7,892 shares (Common Stock) at a price of $79.56 per share, resulting in proceeds of $627,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42K
0% 3M change
17.56% 12M change
Total Value Held $1.86 Million

Prem S Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
SELL
Payment of exercise price or tax liability
$627,887 $79.56 p/Share
7,892 Reduced 15.81%
42,034 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
15,082 Added 28.93%
37,057 Common Stock (restricted)
Feb 26 2024
SELL
Payment of exercise price or tax liability
$19,948 $76.43 p/Share
261 Reduced 0.6%
43,185 Common Stock
Feb 16 2024
SELL
Open market or private sale
$2,267,947 $76.95 p/Share
29,473 Reduced 42.57%
39,764 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
13,313 Added 16.13%
69,237 Common Stock
Aug 31 2023
SELL
Payment of exercise price or tax liability
$228,616 $65.17 p/Share
3,508 Reduced 6.44%
50,987 Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$239,352 $74.31 p/Share
3,221 Reduced 6.13%
49,364 Common Stock
Feb 27 2023
SELL
Payment of exercise price or tax liability
$19,384 $85.77 p/Share
226 Reduced 0.51%
44,403 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
20,376 Added 50.0%
20,376 Common Stock (RSU)
May 31 2022
BUY
Grant, award, or other acquisition
-
20,671 Added 50.0%
20,671 Common Stock (RSU)
Apr 08 2022
SELL
Open market or private sale
$1,780,170 $105.0 p/Share
16,954 Reduced 28.07%
43,453 Common Stock
Apr 08 2022
BUY
Exercise of conversion of derivative security
$860,682 $62.26 p/Share
13,824 Added 21.43%
50,686 Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$2,272,301 $101.09 p/Share
22,478 Reduced 32.55%
46,583 Common Stock
Mar 30 2022
SELL
Open market or private sale
$559,726 $104.7 p/Share
5,346 Reduced 8.3%
59,071 Common Stock
Mar 30 2022
BUY
Exercise of conversion of derivative security
$546,682 $102.26 p/Share
5,346 Added 7.66%
64,417 Common Stock
Mar 17 2022
SELL
Open market or private sale
$493,150 $106.65 p/Share
4,624 Reduced 7.26%
59,071 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$307,647 $104.82 p/Share
2,935 Added 4.52%
62,006 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$14,615 $103.65 p/Share
141 Reduced 0.23%
60,760 Common Stock
Feb 26 2022
SELL
Payment of exercise price or tax liability
$23,572 $104.3 p/Share
226 Reduced 0.38%
59,394 Common Stock
Feb 21 2022
BUY
Grant, award, or other acquisition
-
47,640 Added 44.42%
59,620 Common Stock
PSS

Prem S Shah

EVP and Group President
Woonsocket, RI

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS